Clinical Trial Update: A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab

View source ↗

Summary

A multi-site clinical trial is evaluating how long protective immunity from routine childhood vaccines lasts in participants with B-cell acute lymphoblastic leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (Blincyto) (blinatumomab)

Snippet

Sponsor: Arkansas Children's Hospital Research Institute | Conditions: B-Cell ALL, B-Cell Acute Lymphoblastic Leukaemia | Status: RECRUITING